Source: Eur Respir Monogr 2011; 52: 1-10
Disease area: Interstitial lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. Bilton, A.L. Jones. Bronchiectasis: epidemiology and causes. Eur Respir Monogr 2011; 52: 1-10

Member's Comments

No comment yet.

Related content which might interest you: Non-cystic fibrosis bronchiectasis in children Source: Annual Congress 2005 - MP11 - Non-cystic fibrosis bronchiectasis in children Year: 2005 Bronchiectasis caused by pulmonary tuberculosis: The epidemiology, clinical presentations and the differences from non-tuberculosis-caused bronchiectasis Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013 Is etiology of non-cystic fibrosis bronchiectasis (NCFBE) a risk factor for severe exacerbation? Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature Source: Eur Respir Rev 2012 21: 355-361 Year: 2012 Does non-cystic fibrosis bronchiectasis (nCF-BCt) determine extrapulmonary manifestations? Source: Annual Congress 2013 –Aspects of physiotherapy in various clinical conditions and settings Year: 2013 Etiology and clinical outcome of pediatric non-cystic fibrosis bronchiectasis Source: Annual Congress 2010 - Paediatric epidemiology: infection, prematurity and congenital abnormalities Year: 2010 Diagnosis and management of non-cystic fibrosis bronchiectasis in children Source: International Congress 2018 – Bronchiectasis: new insights in diagnosis and treatment Year: 2018 Idiopathic pulmonary fibrosis (IPF): epidemiology, biology, diagnosis and treatment Source: Virtual Congress 2020 – When the lung gets stiff Year: 2020 Multiple faces of non-cystic fibrosis bronchiectasis: defining etiology and disease severity Source: International Congress 2017 – Management of asthma in different situations Year: 2017 Prevalence of hiatus hernia in non-cystic fibrosis bronchiectasis and associations with disease severity Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Positive microbiology findings in non-cystic fibrosis bronchiectasis and co-morbidities Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Management and prevention of non-cystic fibrosis bronchiectasis Source: International Congress 2015 – PG9 Lower respiratory tract infection in children Year: 2015 Histopathology of bronchiectasis Source: Eur Respir Mon 2011; 52: 22-31 Year: 2011 Characteristic of a subgroup of non cystic fibrosis bronchiectasis with concomitant asthma Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Tuberculosis in patients with idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Cystic fibrosis Source: Respipedia Article Year: 2018 Rare pneumoconioses Source: Annual Congress 2005 - Update on orphan lung diseases Year: 2005 Comparative analysis of the predictive utility of clinical disease severity scores for non-cystic fibrosis bronchiectasis Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 DLCO predicts disease severity and mortality in patients with non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015